The association with PCa risk and treatment implications is better understood for those with variants of BRCA2, with emerging data supporting associations with ATM, CHEK2, BRCA1, HOXB13, MSH2, MSH6 and NBN.18 Here, CHEK2 is linked to posterior cortical atrophy.